SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-07-09
👔
IONIS PHARMACEUTICALS INC
@IONS_InsiderForm 4 Filing: Kordasiewicz Holly B. Sells $30,516.6 of $IONS
INSIDER SALE
⚡ MATERIALITY: 4/10
corporate issuer
IONIS PHARMACEUTICALS INC
Ticker: $IONS
Transaction Value
$30,516.6
Price/Share: $84.30
transaction date
2026-07-07
Shares: 362
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Kordasiewicz Holly B., holds the title of EVP, Chief Development Officer at IONIS PHARMACEUTICALS INC.
On 2026-07-07, the insider transacted 362 shares.The shares were transacted at a weighted average price of $84.30 per share, resulting in a total market-relevant value of $30,516.6.
Executive Summary Summary
Kordasiewicz Holly B. (EVP, Chief Development Officer) sold $31K of $IONS
Post-Transaction Position: 22,096 shares
SEC Accession No: 0000874015-26-000236 (CIK: 2102721)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.